R.F. Kennedy Jr. turns off the money tap, bad for the FRG

RFK Jr. cancels 11.4 billion COVID-19 subsidies

The decision by HHS under Robert F. Kennedy Jr. to cut $11.4 billion in COVID-19 funding is a slap in the face to the Deep State and globalist networks. These funds have previously gone to programmes controlled by the pharmaceutical industry and its lobbyists. This measure will cut the financial lifelines of Big Pharma’s puppets. It is clear that these so-called “health experts” are now crying out loud – their lucrative sources of money are drying up faster than they can invent new diseases.

Big Pharma has a firm grip on global health policy

Big Pharma has had a firm grip on global healthcare policy for decades. Doctors, research institutions and even regulatory authorities are influenced by massive lobbying and financial dependencies. Transparency International speaks of a “structural corruption” that is haemorrhaging healthcare systems worldwide[1][2]. The cuts hit these networks hard and force them to secure their profits elsewhere – for example in countries such as Germany, which remains firmly in the hands of the pharmaceutical lobby [2][3].

Pharmaceutical monopolies deeply rooted in politics

In Germany, the interests of the pharmaceutical monopolies are deeply rooted in politics. The federal government is pursuing a policy that strengthens the influence of these companies and secures their profits. Jens Spahn, former Minister of Health and himself a lobbyist for the pharmaceutical industry, is a prime example of these ties[2]. As America moves away from these structures, Germany is likely to become even more of a target for Big Pharma – a bleak outlook for the German healthcare system.

R.F. Kennedy Jr. turns off the money tap- 3

Pharmaceutical industry strategy: billions in profits through fear and panic

The cuts are part of a larger plan by the Trump administration and Kennedy’s “Make America Healthy Again” (MAHA) initiative. The focus is on chronic diseases rather than invented pandemics. This is a clear rejection of the pharmaceutical industry’s strategy to make billions through fear and panic[3][4]. Americans benefit from this revolution – less taxpayer money for useless programmes and more focus on real health problems.

Good night Germany!

But while America is breaking free, countries like Germany are facing increased dependence on Big Pharma. The industry will turn its attention to markets that have not yet found the courage to fight back against its power. With rising drug prices and growing lobbying, Germany will be further caught in the stranglehold of these corporations[2][4]. The question remains: When will Europe finally wake up?